Sensitive ASX Announcement

Clinuvel to start a Phase II vitiligo study in Singapore

Published: 04/11/13, 09:40am (AEST)2 pages
Clinuvel Pharmaceuticals Limited
CUV:ASXHealthcare

Recent CUV Announcements

Price Sensitive only